Association analysis of formyl peptide receptor 2 (FPR2) polymorphisms and Aspirin exacerbated respiratory diseases
Authors:
- Sung-Hwan ChoSCSung-Hwan Cho
- Jong-Sook ParkJPJong-Sook Park
- Tae-Hyeong LeeTLTae-Hyeong Lee
- Eun-Ju LeeELEun-Ju Lee
- Yong-Hoon KimYKYong-Hoon Kim
- Soo-Taek UhSUSoo-Taek Uh
- Il Yup ChungICIl Yup Chung
- Mi-Kyeong KimMKMi-Kyeong Kim
- Inseon S ChoiICInseon S Choi
- Byung-Lae ParkBPByung-Lae Park
- Hyoung-Doo ShinHSHyoung-Doo Shin
- 1 March 2012
- journal article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 57 (4) , 247-253
Abstract
Aspirin-exacerbated respiratory diseases (AERD) are associated with the metabolism of arachidonic acid. FPR2 (formyl peptide receptor2) is a high-affinity ligand receptor for potent anti-inflammatory lipid metabolites: lipoxins. Thus, functional alterations of the FPR2 may contribute to AERD. We investigated the relationship between single-nucleotide polymorphisms (SNPs) in the FPR2 and AERD. Asthmatics were categorized into AERD G (rs1769490) in intron 2 was significantly lower in the AERD group (n=170) than in the ATA group (n=268) (P=0.006, P(corr)=0.04, recessive model). The decline of FEV(1) after aspirin challenge was significantly lower in the subjects with GG homozygotes of FPR2 -4209T>G than those with the other genotypes (P=0.0002). Asthmatic homozygotes for FPR2 -4209T>G minor allele exhibited significantly higher FPR2 protein expression in CD14-positive monocytes than did those with the common allele of FPR2 -4209T>G allele (P=0.01). There was no difference in the expression of the wild form and the exon 2 deleted variant form of FPR2 gene according to the genotypes of FPR2 -4209T>G. The minor allele at FPR2 -4209T>G may have a protective role against the development of AERD, via increase of FPR2 protein expression in inflammatory cells.Keywords
This publication has 34 references indexed in Scilit:
- Aspirin-Exacerbated Respiratory Disease: Evaluation and ManagementAllergy, Asthma & Immunology Research, 2011
- Diagnostic Value of Clinical Parameters in the Prediction of Aspirin-Exacerbated Respiratory Disease in AsthmaAllergy, Asthma & Immunology Research, 2011
- Association between genetic variations in prostaglandin E2 receptor subtype EP3 gene (Ptger3) and asthma in the Korean populationClinical & Experimental Allergy, 2007
- Clinical and pathologic perspectives on aspirin sensitivity and asthmaJournal of Allergy and Clinical Immunology, 2006
- Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmaticsPharmacogenetics and Genomics, 2005
- Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid‐intolerant asthmaClinical & Experimental Allergy, 2005
- Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approachHuman Molecular Genetics, 2004
- Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenaseHuman Genetics, 2004
- Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and managementJournal of Allergy and Clinical Immunology, 2003
- Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthmaThe Lancet, 1997